Late common iliac artery stent thrombosis in a patient with terminal malignancy

Mehmet M. Can, Brahim H. Tanboǧa, Olcay Özveren, Can Yucel Karabay, Taylan Akgün, Erdem Türkyilmaz, Hacer C. Tokgöz, Cihangir Kaymaz, Victor Serebruany

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Narrowing of the iliac artery is a common presentation of systemic atherosclerosis. With the recent development of invasive techniques, angioplasty and stenting offer excellent results for fixing limb ischemia of aorto-iliac arteries. However, despite novel interventional approaches and constantly increasing experience, complications such as distal embolization, stent migration, acute or subacute iliac artery occlusion, dissection, and perforations are still challenging. Early restenosis and/or reocclusion of peripheral artery stents is uncommon, but the risk of delayed or late thrombotic occlusions of iliac artery stents is unclear. Although with questionable impact, hypercoagulable state or patient noncompliance may contribute to the pathogenesis of stent thrombosis. We describe a patient with terminal renal cell carcinoma who developed late iliac artery stent thrombosis despite dual chronic antiplatelet therapy with aspirin and clopidogrel.

Original languageEnglish (US)
Pages (from-to)307-310
Number of pages4
Issue number4
StatePublished - Apr 2010


  • Iliac artery
  • Malignancy
  • Platelet activity
  • Renal cell carcinoma
  • Stent thrombosis
  • Terminal

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pharmacology (medical)


Dive into the research topics of 'Late common iliac artery stent thrombosis in a patient with terminal malignancy'. Together they form a unique fingerprint.

Cite this